Downregulation of stromal syntenin sustains AML development
Abstract The crosstalk between cancer and stromal cells plays a critical role in tumor progression. Syntenin is a small scaffold protein involved in the regulation of intercellular communication that is emerging as a target for cancer therapy. Here, we show that certain aggressive forms of acute mye...
Saved in:
| Main Authors: | Raphael Leblanc, Rania Ghossoub, Armelle Goubard, Rémy Castellano, Joanna Fares, Luc Camoin, Stephane Audebert, Marielle Balzano, Berna Bou‐Tayeh, Cyril Fauriat, Norbert Vey, Sylvain Garciaz, Jean‐Paul Borg, Yves Collette, Michel Aurrand‐Lions, Guido David, Pascale Zimmermann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2023-10-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202317570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Syntenin Controls Extracellular Vesicle‐Induced Tumour Migration by Regulating the Expression of Adhesion Proteins on Small Extracellular Vesicles
by: Barnabas Irmer, et al.
Published: (2025-08-01) -
Oncostatin M [OSM] protein immuno-expression in oral squamous cell carcinoma – A prospective study
by: Sunil Prakash, et al.
Published: (2024-06-01) -
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
by: Qiu-Shi Feng, et al.
Published: (2025-01-01) -
Ectomesenchymal chondromyxoid tumor: A rare case report
by: Anindita Mondal, et al.
Published: (2024-09-01) -
The Number and Size of Invasion Areas in Mixed-Type Carcinoma in Female Dogs Are Associated with Regional Metastases
by: Fernanda Freitas Miranda, et al.
Published: (2025-03-01)